EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Effectiveness and cost-effectiveness of a multimodal, physiotherapist-led, vocational intervention for people with rheumatoid arthritis or axial spondyloarthritis and a reduced work ability: a randomized, controlled trial

N F Bakker, J Knoop, W B van den Hout, N Hutting, J A Engels, J B Staal, M van der Leeden, A Boonen, A Willemze, M T Nurmohamed, T P M Vliet Vlieland, M G J Gademan und 1 weitere

Rheumatology International · 2025

DOI: 10.1007/s00296-025-06016-w ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Rheumatology International, 2025. Verfasst von N F Bakker und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Rehabilitation and Physical Therapy, Leiden University Medical Center, Albinusdreef 2, P. O. Box 9600, Leiden, 2300 RC, T…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Axial Spondyloarthritis, Rehabilitation, Vocational, Physical Therapists. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Dutch Arthritis Society, Koninklijk Nederlands Genootschap voor Fysiotherapie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To evaluate the (cost-)effectiveness of a physiotherapist-led, multimodal vocational intervention compared to usual care in adults with rheumatoid arthritis (RA) or axial spondyloarthritis (axSpA) experiencing reduced work ability. (Self-)employed people with RA or axSpA and reduced work ability were randomized to a 12-month vocational intervention or usual care. Assessments were conducted at baseline, 3, 6, and 12 months. Primary outcome was the Work Ability index Single-item Scale (WAS) at 12 months. Secondary outcomes included additional work-related and clinical outcomes. Cost-effectiveness was evaluated using the EuroQol to estimate quality-adjusted life years (QALYs), alongside healthcare use and productivity data. Primary analyses followed an intention-to-treat approach. A total of 140 participants (80 RA, 60 axSpA) were randomized 1:1 to the intervention or control group. At 12 months, the intervention showed no significant benefits over usual care on the WAS (estimated mean difference (MD): 0.40, 95% confidence interval (CI): - 0.22, 1.01) or any of the secondary outcomes. The QALYs were in favor of the intervention group by 0.05. The mean intervention costs were €395 per participant (90% usage, mean 9.5 sessions). After 12 months, the societal costs were €4324 lower in the intervention group (95% CI €-8169, €-479), mainly due to higher medication and presenteeism costs in the control group. At a willingness-to-pay threshold of €20.000/QALY, the intervention had a 99% probability of being cost-effective compared to usual care. While the intervention did not affect work ability in individuals with RA or axSpA, it outperformed usual care from a health-economic perspective, demonstrating its cost-effectiveness and potential value. International Clinical Trial Registry Platform (ICTRP) registration link: ICTRP Search Portal.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidAxial SpondyloarthritisRehabilitation, VocationalPhysical TherapistsPhysical Therapy ModalitiesHumansCost-Benefit AnalysisFemaleMaleMiddle AgedAdultQuality-Adjusted Life YearsTreatment OutcomeWork Capacity EvaluationAbsenteeismHealth Care CostsTime Factors

Stichwörter der Autor:innen

Axial spondyloarthritisCost-utilityPhysical therapy modalitiesRandomized controlled trialRheumatoid arthritisVocational rehabilitation

Autor:innen und Institutionen

  • Department of Orthopaedics, Rehabilitation and Physical Therapy, Leiden University Medical Center, Albinusdreef 2, P. O. Box 9600, Leiden, 2300 RC, The Netherlands. n.f.bakker@lumc.nl.
  • Musculoskeletal Rehabilitation Research Group, HAN University of Applied Sciences, Nijmegen, The Netherlands.
  • Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.
  • Research Group Occupation and Health, HAN University of Applied Sciences, Nijmegen, The Netherlands.
  • IQ health, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Reade, Rehabilitation and Rheumatology, Amsterdam, The Netherlands.

Förderung

  • Dutch Arthritis Society
  • Koninklijk Nederlands Genootschap voor Fysiotherapie

Zitieren

APA

Bakker, N. F., Knoop, J., van den Hout, W. B., Hutting, N., Engels, J. A., Staal, J. B., van der Leeden, M., Boonen, A., Willemze, A., Nurmohamed, M. T., Vliet Vlieland, T. P. M., Gademan, M. G. J., & van Weely, S. F. E. (2025). Effectiveness and cost-effectiveness of a multimodal, physiotherapist-led, vocational intervention for people with rheumatoid arthritis or axial spondyloarthritis and a reduced work ability: a randomized, controlled trial. Rheumatology International. https://doi.org/10.1007/s00296-025-06016-w

Vancouver

Bakker NF, Knoop J, van den Hout WB, Hutting N, Engels JA, Staal JB, et al. Effectiveness and cost-effectiveness of a multimodal, physiotherapist-led, vocational intervention for people with rheumatoid arthritis or axial spondyloarthritis and a reduced work ability: a randomized, controlled trial. Rheumatology International. 2025. doi:10.1007/s00296-025-06016-w

BibTeX
@article{Bakker2025,
  author = {Bakker, N F and Knoop, J and van den Hout, W B and Hutting, N and Engels, J A and Staal, J B and van der Leeden, M and Boonen, A and Willemze, A and Nurmohamed, M T and Vliet Vlieland, T P M and Gademan, M G J and van Weely, S F E},
  title = {Effectiveness and cost-effectiveness of a multimodal, physiotherapist-led, vocational intervention for people with rheumatoid arthritis or axial spondyloarthritis and a reduced work ability: a randomized, controlled trial},
  journal = {Rheumatology International},
  year = {2025},
  doi = {10.1007/s00296-025-06016-w}
}
Kostenlos starten →